Ovarian Cancer Test OvaSure Being Marketed Without Necessary FDA Approval

The U.S. Food and Drug Administration warned clinical test giant Laboratory Corp. of America Holdings that it was marketing OvaSure, an ovarian cancer test, in violation of the law in that it did not have marketing clearance or approval from the FDA.

OvaSure measures six proteins in blood samples and calculates the chances that the woman has ovarian cancer. LabCorp … Read the rest